Healthcare & Life Sciences
Spica Therapeutics
Belgium
seed
seed
Stage
1
Investors
About
Spica Therapeutics develops therapies that selectively target specific macrophage subsets to modulate immune responses. The company is listed as a VUB-associated portfolio company of Qbic Venture Partners.
Explore Spica Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.